Erratum: The prevention and management of rabies (BMJ (Online) (2015) 350 (g7827) DOI 10.1136/bmj.g7827);The prevention and management of rabies

BMJ (Online)

Volumn 350, Issue , 2015, Pages

  Crowcroft, Natasha S ^a   Thampi, Nisha ^b  

^a PUBLIC HEALTH ONTARIO   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; RABIES IMMUNOGLOBULIN; RABIES VACCINE; RIBAVIRIN; IMMUNOGLOBULIN;

ANTIVIRAL ACTIVITY; CASE MANAGEMENT; CLINICAL FEATURE; DOG BITE; HUMAN; INCUBATION TIME; INFECTION PREVENTION; NONHUMAN; PALLIATIVE THERAPY; PRE EXPOSURE VACCINATION; RABIES; REVIEW; RISK ASSESSMENT; TRAVEL; TREND STUDY; VACCINATION; VIRAL CLEARANCE; VIRUS LOAD; VIRUS TRANSMISSION; WOUND CARE; BITES AND STINGS; COMPLICATION; COST OF ILLNESS; DISEASE ERADICATION; DRUG ADMINISTRATION; DRUG ADMINISTRATION ROUTE; EMPORIATRICS; HEALTH; PATIENT EDUCATION; RISK FACTOR; TRANSMISSION;

BITES AND STINGS; COST OF ILLNESS; DISEASE ERADICATION; DRUG ADMINISTRATION ROUTES; DRUG ADMINISTRATION SCHEDULE; GLOBAL HEALTH; HUMANS; IMMUNOGLOBULINS; PATIENT EDUCATION AS TOPIC; RABIES; RABIES VACCINES; RISK FACTORS; TRAVEL MEDICINE;

EID: 84921334136     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.h575     Document Type: Erratum

References (41)

1. Wunner WH, Briggs DJ. Rabies in the 21 century. PLoS Negl Trop Dis 2010;4:e591.
2. World Health Organization. WHO expert consultation on rabies: second report. WHO Press, 2013.
3. Nel LH. Discrepancies in data reporting for rabies, Africa. Emerg Infect Dis 2013;19:529-33.
4. Fitzpatrick MC, Hampson K, Cleaveland S, Mzimbiri I, Lankester F, Lembo T, et al. Cost-effectiveness of canine vaccination to prevent human rabies in rural Tanzania. Ann Intern Med 2014;160:91-100.
5. Shim E, Hampson K, Cleaveland S, Galvani AP. Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: a case study in Tanzania. Vaccine 2009;27:7167-72.
6. Rumana R, Sayeed AA, Basher A, Islam Z, Rahman MR, Faiz MA.. Perceptions and treatment seeking behavior for dog bites in rural Bangladesh. Southeast Asian J Trop Med Public Health 2013;44:244-8.
7. De Serres G, Skowronski DM, Mimault P, Ouakki M, Maranda-Aubut R, Duval B. Bats in the bedroom, bats in the belfry: reanalysis of the rationale for rabies postexposure prophylaxis. Clin Infect Dis 2009;48:1493-9.
8. Tsiodras S, Dougas G, Baka A, Billinis C, Doudounakis S, Balaska A, et al. Re-emergence of animal rabies in northern Greece and subsequent human exposure, October 2012-March 2013. Euro Surveill 2013;18:20474.
9. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2197-223.
10. Lembo T, Hampson K, Kaare MT, Ernest E, Knobel D, Kazwala RR, et al. The feasibility of canine rabies elimination in Africa: dispelling doubts with data. PLoS Negl Trop Dis 2010;4:e626.
11. Zinsstag J. Towards a science of rabies elimination. Infect Dis Poverty 2013;2:22.
12. Public Health England. Rabies. 2013. www.hpa.org.uk/Topics/InfectiousDiseases/ InfectionsAZ/Rabies/GeneralInformation/.
13. Vigilato MA, Cosivi O, Knöbl T, Clavijo A, Silva HM. Rabies update for Latin America and the Caribbean. Emerg Infect Dis 2013;19:678-9.
14. Public Health Laboratory Service. Fatal infection with European bat lyssavirus rabies-related virus in Scotland. Commun Dis Rep CDR Wkly 2002;12(48). www.hpa.org.uk/cdr/archives/2002/cdr4802.pdf.
15. Johnstone J, Saxinger L, McDermid R, Bagshaw S, Resch L, Lee B, et al. Human rabies-Alberta, Canada, 2007. MMWR Morb Mortal Wkly Rep 2008;57:197-200.
16. Helmick CG, Tauxe RV, Vernon AA. Is there a risk to contacts of patients with rabies? Rev Infect Dis 1987;9:511-8.
17. Carrara P, Parola P, Brouqui P, Gautret P. Imported human rabies cases worldwide, 1990-2012. PLoS Negl Trop Dis 2013;7:e2209.
18. Bourhy H, Dautry-Varsat A, Hotez PJ, Salomon J. Rabies, still neglected after 125 years of vaccination. PLoS Neglect Trop Dis 2010;4:e839.
19. Centers for Disease Control and Prevention. Rabies in a laboratory worker-New York. MMWR Morb Mortal Wkly Rep 1977;26:183-4.
20. Winkler WG, Fashinell TR, Leffingwell L, Howard P, Conomy P. Airborne rabies transmission in a laboratory worker. JAMA 1973;226:1219-21.
21. Both L, Banyard AC, van Dolleweerd C, Horton DL, Ma JK, Fooks AR. Passive immunity in the prevention of rabies. Lancet Infect Dis 2012;12:397-407.
22. Madhusudana SN, Mani RS. Intradermal vaccination for rabies prophylaxis: conceptualization, evolution, present status and future. Expert Rev Vaccines 2014;13:641-55.
23. Kaul DR. Donor-derived infections with central nervous system pathogens after solid organ transplantation. JAMA 2013;310:378-9.
24. Bronnert J, Wilde H, Tepsumethanon V, Lumlertdacha B, Hemachudha T. Organ transplantations and rabies transmission. J Travel Med 2007;14:177-80.
25. Vora NM, Basavaraju SV, Feldman KA, Paddock CD, Orciari L, Gitterman S, et al. Raccoon rabies virus variant transmission through solid organ transplantation. JAMA 2013;310:398-407.
26. Wilde H. Failures of post-exposure rabies prophylaxis. Vaccine 2007;25:7605-9.
27. Wilde H, Sirikawin S, Sabcharoen A, Kingnate D, Tantawichien T, Harischandra PA, et al. Failure of postexposure treatment of rabies in children. Clin Infect Dis 1996;22:228-32.
28. Maier T, Schwarting A, Mauer D, Ross RS, Martens A, Kliem V, et al. Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus. Clin Infect Dis 2010;50:1112-9.
29. Morimoto K, Patel M, Corisdeo S, Hooper DC, Fu ZF, Rupprecht CE, et al. Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America. Proc Natl Acad Sci U S A 1996;93:5653-8.
30. Rupprecht CE, Briggs D, Brown CM, Franka R, Katz SL, Kerr HD, et al. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 2010;59(RR-2):1-9.
31. Bernard KW, Smith PW, Kader FJ, Moran MJ. Neuroparalytic illness and human diploid cell rabies vaccine. JAMA 1982;248:3136-8.
32. Knobel DL, Cleaveland S, Coleman PG, Fèvre EM, Meltzer MI, Miranda ME, et al. Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 2005;83:360-8.
33. Sudarshan MK, Mahendra BJ, Madhusudana SN, Ashwoath Narayana DH, Rahman A, Rao NS, et al. An epidemiological study of animal bites in India: results of a WHO sponsored national multi-centric rabies survey. J Commun Dis 2006;38:32-9.
34. Smith JS, Fishbein DB, Rupprecht CE, Clark K. Unexplained rabies in three immigrants in the United States. A virologic investigation. N Engl J Med 1991;324:205-11.
35. Hemachudha T, Laothamatas J, Rupprecht CE. Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet Neurol 2002;1:101-9.
36. Hemachudha T, Phanthumchinda K, Phanuphak P, Manutsathit S. Myoedema as a clinical sign in paralytic rabies. Lancet 1987;1:1210.
37. Noah DL, Drenzek CL, Smith JS, Krebs JW, Orciari L, Shaddock J, et al. Epidemiology of human rabies in the United States, 1980 to 1996. Ann Intern Med 1998;128:922-30.
38. Udow SJ, Marrie RA, Jackson AC. Clinical features of dog- and bat-acquired rabies in humans. Clin Infect Dis 2013;57:689-96.
39. Willoughby RE Jr, Tieves KS, Hoffman GM, Ghanayem NS, Amlie-Lefond CM, Schwabe MJ, et al. Survival after treatment of rabies with induction of coma. N Engl J Med 2005;352:2508-14.
40. Jackson AC. Current and future approaches to the therapy of human rabies. Antiviral Res 2013;99:61-7.
41. Jentes ES, Blanton JD, Johnson KJ, Petersen BW, Lamias MJ, Robertson K et al. The global availability of rabies immune globulin and rabies vaccine in clinics providing indirect care to travelers. J Travel Med 2014;21:62-6.